Announcements

18NOV

Removal of Component(s) – CELG

11/18/2019 Effective at the market close on Wednesday, November 20, 2019, CELG will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights. On January 3, 2019, Celgene Corporation (CELG) announced that it will be acquired by Bristol-Myers Squibb Company for $50.00 per share in cash, one share of BMY and one CVR for each share of CELG.
18OCT

Removal of Component(s) – ALDR

LifeSci Biotechnology Clinical Trials Index   Effective at the market close on Monday, October 21, 2019, ALDR will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On September 16, 2019, Alder BioPharmaceuticals (ALDR) announced that it will be acquired by Biogen Inc. for $18.00 per share in cash along with one non-tradeable contingent value right.  
30JUL

Removal of Component(s) – ARRY

LifeSci Biotechnology Products Index Removal of Component(s) – ARRY 7/30/2019   Today, Pfizer announced that it has closed its previously announced acquisition of Array Biopharma (ARRY).  As a result, effective at the market close on Wednesday, July 31, 2019, the value of ARRY will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.  
14JUN

Index Semi-Annual Reconstitution (Final) - June 2019

LifeSci Biotechnology Products Index LifeSci Biotechnology Clinical Trials Index   The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Tuesday, June 18, 2019.  All positions will be equally weighted, with weights determined as of the closing prices on Friday, June 14, 2019.  The preliminary changes, subject to modification, are summarized below.   LifeSci Biotechnology Clinical Trials Index Additions (17 stocks): -   ADVM, ALEC, ALLO, ARVN, AXSM, FTSV, GOSS, GRTS, KALV, KRYS, MGTA, MGTX, MRNA, MYOV, ORTX, PHAS, THOR Deletions (16 stocks): -  ADAP, APTX, ASRT, CRNX, FPRX, INO, KDMN, KNSA, MRKR, NVAX, OPTN, SAGE, SLDB, STIM, STML,
10JUN

Index Semi-Annual Reconstitution (Preliminary) - June 2019

Index Semi-Annual Reconstitution (Preliminary) The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Tuesday, June 18, 2019.  All positions will be equally weighted, with weights determined as of the closing prices on Friday, June 14, 2019.  The preliminary changes, subject to modification, are summarized below. LifeSci Biotechnology Clinical Trials Index Additions (17 stocks): ADVM, ALEC, ALLO, ARVN, AXSM, FTSV, GOSS, GRTS, KALV, KRYS, MGTA, MGTX, MRNA, MYOV, ORTX, PHAS, THOR Deletions (16 stocks): ADAP, APTX, ASRT, CRNX, FPRX, INO, KDMN, KNSA, MRKR, NVAX, OPTN, SAGE, SLDB, STIM, STML, SVRA Summary: The updated index will have 95 equal-weighted components
03JUN

Removal of Component(s) - NITE

LifeSci Biotechnology Clinical Trials Index Removal of Component(s) – NITE 6/3/2019 Effective at the market close on Thursday, June 6, 2019, NITE will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On 3/4/2019, Nightstar Therapeutics plc (NITE) announced that it will be acquired by Biogen Inc. for $25.50 per share in cash. 
01APR

Removal of Component(s) - ONCE

LifeSci Biotechnology Products Index Removal of Component(s) – ONCE 4/1/2019 Effective at the market close on Wednesday, April 3, 2019, ONCE will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights. On 2/25/2019, Spark Therapeutics (ONCE) announced that it will be acquired by Roche AG for $114.50 per share in cash. 
13DEC

Index Semi-Annual Reconstitution (Final) - December 2018

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, December 17, 2018.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, December 13, 2018.   LifeSci Biotechnology Clinical Trials Index Additions (23 stocks): -          ALLK, AMRS, APTX, ASND, ASRT, AUTL, AVRO, CRNX, DRNA, EIDX, KDMN, KNSA, MRKR, NITE, OPTN, PRNB, PRQR, RARX, STIM, SVRA, TCDA, UBX, WVE Deletions (26 stocks): -          ADRO, ADVM, AKAO, ALBO, ALNY, ARRY, AVEO, AXON, BLCM, CBIO, CLSD, ECYT, FOLD, IDRA, LOXO, MLNT, MNOV, MRNS, PIRS, PRTK, RCUS, SELB, SGYP, SYRS, TORC, VSTM Summary: -         
10DEC

Index Semi-Annual Reconstitution (Preliminary) - December 2018

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, December 17, 2018.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, December 13, 2018.  The preliminary changes, subject to modification, are summarized below. LifeSci Biotechnology Clinical Trials Index Additions (24 stocks):  ALLK, AMRS, APTX, ASND, ASRT, AUTL, AVRO, CRNX, DRNA, EIDX, KDMN, KNSA, MRKR, NITE, OPTN, PRNB, PRQR, RARX, STIM, SVRA, TCDA, TOCA, UBX, WVE Deletions (26 stocks):  ADRO, ADVM, AKAO, ALBO, ALNY, ARRY, AVEO, AXON, BLCM, CBIO, CLSD, ECYT, FOLD, IDRA, LOXO, MLNT,
14JUN

LifeSci Biotechnology Indexes: Semi-Annual Reconstitution (Final)

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, June 18, 2018.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, June 14, 2018.  (There are no changes to the preliminary index changes announced on June 8, 2018.) LifeSci Biotechnology Clinical Trials Index Additions (27 stocks): ADAP, ADVM, ALBO, APLS, ARQL, ARWR, BHVN, CBIO, CCXI, CLSD, DCPH, DNLI, ECYT, FATE, MNOV, PGNX, RCKT, RCUS, RYTM, SELB, SGYP, SLDB, SRNE, SYRS, TORC, VKTX, VSTM Deletions (11 stocks): AGIO, ARDX, CALA, CLDX, DOVA, JNCE, MCRB, NLNK, RARE, RIGL,
08JUN

LifeSci Biotechnology Index Semi-Annual Reconstitution (Preliminary)

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, June 18, 2018.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, June 14, 2018.  The preliminary changes, subject to modification, are summarized below. LifeSci Biotechnology Clinical Trials Index Additions (27 stocks): ADAP, ADVM, ALBO, APLS, ARQL, ARWR, BHVN, CBIO, CCXI, CLSD, DCPH, DNLI, ECYT, FATE, MNOV, PGNX, RCKT, RCUS, RYTM, SELB, SGYP, SLDB, SRNE, SYRS, TORC, VKTX, VSTM Deletions (11 stocks): AGIO, ARDX, CALA, CLDX, DOVA, JNCE, MCRB, NLNK, RARE, RIGL, TTPH Summary: The updated index will have 98
09MAY

Removal of Component(s) - AVXS

LifeSci Biotechnology Clinical Trials Index Removal of Component(s) – AVXS 5/9/2018 Effective at the market close on Monday, May 14, 2018, AVXS will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On 4/9/2018, AveXis (AVXS) announced that it will be acquired by Novartis AG for $218 per share in cash. 
06FEB

Removal of Component(s) - RXDX, JUNO, BIVV

LifeSci Biotechnology Clinical Trials Index LifeSci Biotechnoloogy Products Index Removal of Component(s) – RXDX, JUNO, BIVV 2/6/2018   Effective at the market close on Thursday, February 8, 2018, RXDX and JUNO will be removed from the LifeSci Biotechnology Clinical Trials Index and their combined values will be redistributed to the remaining index components based on their weights. On 12/22/2017, Ignyta (RXDX) announced that it will be acquired by Roche for $27 per share in cash.  On 1/22/2018, Juno Therapeutics (JUNO) announced that it will be acquired by Celgene for $87 per share in cash.  Effective at the market close on Thursday, February 8, 2018, BIVV will be removed
14DEC

LifeSci Biotechnology Index Semi-Annual Reconstitution

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, December 18, 2017.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, December 14, 2017.